Market Exclusive

Analyst Activity – HC Wainwright Reiterates Buy on BioCryst Pharmaceuticals (NASDAQ:BCRX)

Analyst Ratings For BioCryst Pharmaceuticals (NASDAQ:BCRX)

Today, HC Wainwright reiterated its Buy rating on BioCryst Pharmaceuticals (NASDAQ:BCRX) with a price target of $10.00.

Some recent analyst ratings include

Recent Insider Trading Activity For BioCryst Pharmaceuticals (NASDAQ:BCRX)
BioCryst Pharmaceuticals (NASDAQ:BCRX) has insider ownership of 5.60% and institutional ownership of 84.69%.

Recent Trading Activity for BioCryst Pharmaceuticals (NASDAQ:BCRX)
Shares of BioCryst Pharmaceuticals closed the previous trading session at 5.55 up +0.23 4.32% with 309765 shares trading hands.

Exit mobile version